Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00343434 · ClinicalTrials.gov registry record · NA
Soy-Based Meal Replacement in Helping Women With Stage I, Stage II, or Stage III Breast Cancer in Complete Remission Lose Weight
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT00343434 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 25 participants.
The verdict
NCT00343434, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
RATIONALE: A diet using a soy-based meal replacement may help survivors of breast cancer lose weight and improve their quality of life. PURPOSE: This clinical trial is studying how well a soy-based meal replacement works in helping women with stage I, stage II, or stage III breast cancer in complete remission lose weight.
Interventions
- BEHAVIORAL exercise intervention
- OTHER counseling intervention
- BEHAVIORAL behavioral dietary intervention
- DIETARY_SUPPLEMENT soy protein isolate
- DIETARY_SUPPLEMENT soy isoflavones
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2005-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00343434
The ClinicalTrials.gov registry entry for NCT00343434 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which exercise intervention is the first listed.
NCT00343434 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00343434 about?
NCT00343434 is a clinical study titled "Soy-Based Meal Replacement in Helping Women With Stage I, Stage II, or Stage III Breast Cancer in Complete Remission Lose Weight". RATIONALE: A diet using a soy-based meal replacement may help survivors of breast cancer lose weight and improve their quality of life. PURPOSE: This clinical trial is studying how well a soy-based meal replacement works in helping women with stage I, stage II, or stage III breast cancer in complet...
What is the current status of trial NCT00343434?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2005-01.
What interventions are being tested in trial NCT00343434?
The interventions under investigation include: exercise intervention (BEHAVIORAL), counseling intervention (OTHER), behavioral dietary intervention (BEHAVIORAL), soy protein isolate (DIETARY_SUPPLEMENT), soy isoflavones (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00343434?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.